Max Levin

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 389 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Evidence of Hypoxic Areas Within the Arterial Wall In Vivo

Tom Björnheden, Max Levin, M. Evaldsson et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 280 citations · Full text

Life Sciences, Pathology, Physiology +15

Metabolic effects of <i> <scp>L</scp> actobacillus reuteri </i> <scp>DSM</scp> 17938 in people with type 2 diabetes: <scp>A</scp> randomized controlled trial

Reza Mobini, Valentina Tremaroli, Marcus Ståhlman et al. · Diabetes Obesity and Metabolism · 2016 · 266 citations

Agriculture, Nutrition, Nutritional Sciences +17

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma

Lars Ny, Henrik Jespersen, Joakim Karlsson et al. · Nature Communications · 2021 · 180 citations · Full text

Medicine, Oncology, Pharmacology +16

Kidney Hypoxia, Attributable to Increased Oxygen Consumption, Induces Nephropathy Independently of Hyperglycemia and Oxidative Stress

Malou Friederich‐Persson, Erik Thorn, Peter Hansell et al. · Hypertension · 2013 · 179 citations · Full text

Life Sciences, Pharmacology, Physiology +17